Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma

Published:2019-01-01 Issue:1 Volume:36 Page:219-227
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Liu Changfu¹,Cao Fei¹,Xing Wenge¹,Si Tongguo¹,Yu Haipeng¹,Yang Xueling¹,Guo Zhi¹

Affiliation:

1. Department of Interventional Treatment, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2018.1556819

Reference32 articles.

1. The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma

2. Cancer statistics, 2013

3. Renal-Cell Carcinoma

4. Renal cell carcinoma: Current status and future prospects

5. Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review;Expert Review of Anticancer Therapy;2024-06-03

2. Investigation of Lung Cancer Cell Response to Cryoablation and Adjunctive Gemcitabine-Based Cryo-Chemotherapy Using the A549 Cell Line;Biomedicines;2024-06-03

3. Cost-effectiveness analysis of anlotinib versus sunitinib as first-line treatment for metastatic renal cell carcinoma in China;PLOS ONE;2023-02-07

4. Progress in the cryoablation and cryoimmunotherapy for tumor;Frontiers in Immunology;2023-01-25

5. Advanced Nanomaterials for the Diagnosis and Treatment of Renal Cell Carcinoma;Advanced NanoBiomed Research;2022-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3